Antibiotic therapy of the CAP at young patients from different social groups Source: Eur Respir J 2003; 22: Suppl. 45, 451s Year: 2003
Antibiotic usage analysis for community-acquired pneumonia (CAP) treatment Source: Annual Congress 2009 - Pulmonary infections Year: 2009
Microbiological study of community acquired pneumonia versus nosocomial pneumonia in pediatric age group Source: Eur Respir J 2004; 24: Suppl. 48, 714s Year: 2004
Comparison of different models of azithromycin treatment of patients with no severe community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 166s Year: 2006
Evaluation of different predictive rules in young adults died from community-acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005
Determinants of performance of indicators on antibiotic use in community-acquired pneumonia (CAP) at hospitals Source: Eur Respir J 2005; 26: Suppl. 49, 638s Year: 2005
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2010; 36: 128-134 Year: 2010
Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Anti-Pseudomonas antibiotic use for hospitalized patients with community-acquired pneumonia Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020
Antibiotic management of nosocomial pneumonia in children Source: Eur Respir J 2006; 28: Suppl. 50, 633s Year: 2006
Etiology and antibiotic resistance patterns in adults with severe community-acquired pneumonia in Russia Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019
Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005
Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009
Antibiotic prescription patterns in hospitalized patients with community-acquired pneumonia in local hospital: 10 year follow-up Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study Source: ERJ Open Res, 4 (4) 00096-2018; 10.1183/23120541.00096-2018 Year: 2018
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020
Evolution of antimicrobial resistance trends in the last five years in patients with bacteremic Pneumococcal community-acquired pneumonia (CAP-SP) Source: Eur Respir J 2005; 26: Suppl. 49, 639s Year: 2005
Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis Source: Eur Respir J 2008; 31: 1068-1076 Year: 2008
Are there differences in Pneumonia sp. pneumoniae in patients with community-acquired pneumonia patients and institutionalized? Source: Annual Congress 2009 - Pulmonary infections Year: 2009
Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002